CLINICAL_TRIALS
trial_result
· 2014-04-07
Clinical Trial Update: Mirasol-Treated Platelets - (Pathogen Reduction Extended Storage Study) [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 study of Mirasol-treated platelets for thrombocytopenia was terminated; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Terumo BCTbio | Conditions: Thrombocytopenia | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2014-04-07